USA |PINK |USD
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||20.69%||Ex-Dividend Date|
|Held by Institutions||36.41%||IPO Date||-|
|Dec 20||Dec 19||Dec 18|
|Jun 21||Mar 21||Dec 20|
Acacia pharma group trades on the OTC Markets stock market in USA under the ticker symbol "ACPGF". Acacia pharma group’s stock symbol can also be displayed as "OTCMKTS:ACPGF".
Acacia pharma group (OTCMKTS:ACPGF) is owned by 36.41% institutional shareholders and by 20.69% insiders. The rest is owned by the public.
Explore More Details on Acacia pharma group's “Ownership” Section
Acacia pharma group's key executive team includes the following managers:
Acacia pharma group (OTCMKTS:ACPGF) is classified under the "" sector and under the "" industry.
Currently the number of employees working for Acacia pharma group is 72.
Acacia pharma group (OTCMKTS:ACPGF) is headquartered in United Kingdom.
Acacia pharma group’s mailing address is The Officers? Mess, Cambridge, United Kingdom, CB22 4QH.
The company’s phone number is 44 1223 919760.